Evidence map›Paper›PMID 27573339›Full record

ArticleClinical and experimental nephrology2017

Novel NPHS2 variant in patients with familial steroid-resistant nephrotic syndrome with early onset, slow progression and dominant inheritance pattern.

Maija Suvanto, Jaakko Patrakka, Timo Jahnukainen, Pia-Maria Sjöström, Matti Nuutinen, Pekka Arikoski, Janne Kataja, Marjo Kestilä, Hannu Jalanko

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental nephrology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. BioMed research international · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Maija SuvantoChildren's Hospital, University of Helsinki and Helsinki University Hospital, Biomedicum 2U, Tukholmankatu 8, 00290, Helsinki, Finland. maija.suvanto@helsinki.fi.ORCID http://orcid.org/0000-0001-9271-7778
Jaakko PatrakkaDepartment of Medical Biochemistry and Biophysics, Division of Matrix Biology, Karolinska Institute, Stockholm, Sweden.
Timo JahnukainenChildren's Hospital, University of Helsinki and Helsinki University Hospital, Biomedicum 2U, Tukholmankatu 8, 00290, Helsinki, Finland.
Pia-Maria SjöströmDepartment of Pediatrics, District Hospital of Pietarsaari, Pietarsaari, Finland.
Matti NuutinenDepartment of Pediatrics, University Hospital of Oulu, Oulu, Finland.
Pekka ArikoskiDepartment of Pediatrics, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland.
Janne KatajaDepartment of Pediatrics, University Hospital of Turku, Turku, Finland.
Marjo KestiläDepartment of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.
Hannu JalankoChildren's Hospital, University of Helsinki and Helsinki University Hospital, Biomedicum 2U, Tukholmankatu 8, 00290, Helsinki, Finland.
University of Helsinki · FIFinnish Institute for Health and Welfare · FIKarolinska Institutet · SEOulu University Hospital · FITurku University Hospital · FIUniversity of Eastern Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSteroid-resistant nephrotic syndrome (SRNS) is a common cause of end-stage renal disease in children but also occurs as an adult-onset condition. In a subset of SRNS patients, pathogenic variants are found in genes coding for podocyte foot process proteins. The aim of this study was to define the role of pathogenic variants in Finnish patients with familial and sporadic SRNS.

methodsWe analyzed SRNS-related genes NPHS1, NPHS2, NEPH1, ACTN4, TRPC6, INF2, WT1, CD2AP, LAMB2, and PLCE1 for disease-causing variants using direct sequencing of exons and intron/exon boundaries in all members of a family with dominant SRNS with early onset and slow progression to end-stage renal disease. We carried out a whole genome sequencing in two affected and two healthy family members. The function of found podocin variant was studied using co-immunoprecipitation and immunohistochemistry. Podocyte gene sequences were analyzed in a cohort of Finnish non-familial SRNS patients.

resultsA heterozygous de novo deletion, c.988_989delCT in NPHS2, was found in all affected family members and in none of their healthy relatives, non-familial patients or controls. No other SRNS-related gene variant, coding or non-coding co-segregated with the disease phenotype in the family. While the truncated podocin remained able to bind nephrin, the expression of nephrin was fragmented and podocin expression reduced. The gene analysis of the non-familial SRNS patients revealed few variants.

conclusionThe role of podocin variants in nephrotic syndrome may be more varied than previously thought.

Indexed as

Genes, DominantSequence DeletionAdolescentAdultChildChild, PreschoolDisease ProgressionDNA Mutational AnalysisDrug ResistanceFinlandGenetic MarkersGenetic Predisposition to DiseaseGenome-Wide Association StudyHeredityHeterozygoteHumansGenetic MarkersIntracellular Signaling Peptides and ProteinsMembrane ProteinsNPHS2 proteinSteroidsGlomerulusPodocinPodocyte

Identifiers

PMID27573339
OpenAlexW2508160713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.